Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on qPCR and dPCR Instrumentation. The global market for qPCR and dPCR Instrumentation is forecast to reach US$3.9 billion by 2020, driven by continuous advancements in nucleic acid detection and quantification and the rapidly shifting focus of molecular biology research from cataloguing genes and mRNA towards quantifying nucleic acid molecules.

qPCR and dPCR Instrumentation: A Global Strategic Business Report

Follow us on LinkedIn - Polymerase Chain Reaction (PCR) represents one of the fastest growing technologies in the life sciences industry. Growing global interest among cell biologists in subcellular visualization is driving growth in nucleic acid detection technologies like qPCR and dPCR. The need for deeper understanding of gene expressions will continue to benefit the qPCR and dPCR instruments and reagents market. Expanding applications in fields ranging from pharma, biotech, food & beverage to animal feed, will additionally spur growth in the market. The Human Genome Project and other recent advancements in molecular diagnostics and genetics have created significant demand for qPCR and dPCR in a wide range of markets, such as drug discovery, disease diagnosis, life sciences research, and forensics, among others. Falling cost of nucleic acid detection, quantification, and amplification techniques will additionally encourage adoption of qPCR and dPCR instrumentation in research and diagnosis in developing resource poor countries.

In multi-factorial diseases like cancer there is an acute need for accurate and reliable molecular diagnostic, prognostic, and predictive testing techniques. Under this scenario, qPCR is finding new applications in tumor profiling. Digital PCR, on the other hand, is being increasingly used in monitoring targeted drug therapies with Herceptin. The emergence of single-cell molecular-biology is forecast to spur demand for single-cell qPCR, given the limitation associated with conventional RNA methods in handling the cellular heterogeneity of tissue cells. Key factors driving the growth of single-cell molecular-biology include adoption of advanced genomic tools, development of Next-Generation Sequencing (NGS), and the establishment of dedicated institutions. Education and Research constitutes the largest end-use market for qPCR and dPCR instrumentation. Testing Laboratories will however spur future growth in the market.

Quantitative PCR represents the largest product market supported by a large installed base, and technology benefits such as affordability, user-familiarity, and broad application possibilities. While qPCR is a relatively mature market, dPCR represents an emerging market driven by the strong demand for high-precision nucleic acid quantification and viral detection. The need to improve the throughput and multiplexing capabilities of qPCR systems is resulting in the integration of automation robotic systems, such as liquid handling robots in pharmaceutical and government research laboratories.

As stated by the new market research report on qPCR and dPCR Instrumentation, the United States represents the largest market worldwide. Asia-Pacific is forecast to spearhead global growth with a CAGR of 7.2% over the analysis period, led by the increased use of qPCR in blood donor testing & screening and diagnosis of tropical diseases like Malaria. Other macroeconomic factors encouraging growth in the region include increase in government and consumer per-capita spending on healthcare, expanding healthcare needs compounded by the medical tourism trend and the ensuing need to improve the quality of diagnosis and treatment.

Major players covered in the report include Agilent Technologies; Becton, Dickinson and Company; BioFire Diagnostics Inc.; Bio-Rad Laboratories Inc.; Cepheid; Eppendorf AG; Exiqon A/S; F. Hoffmann-La Roche Ltd.; Fluidigm Corp.; Illumina Inc.; Promega Corp.; RainDance Technologies Inc.; Qiagen N.V.; Takara Bio Inc.; Thermo Fisher Scientific Inc.; among others.

The research report titled “qPCR and dPCR Instrumentation: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the market trends, growth drivers, challenges, mergers and acquisitions; and other strategic industry activities of major companies. The report provides market estimates and projections for qPCR and dPCR Instrumentation in value (US$ Thousand) for major geographic markets, including the US, Canada, Japan, Europe (France, Germany, Italy, UK, and Rest of Europe), Asia-Pacific (China, and Rest of Asia-Pacific), The Middle East & Africa, and Latin America. The report also analyzes the global market for qPCR and dPCR Instrumentation by major product segments, namely qPCR and dPCR, and by major product categories: Reagents and Instruments. End-use segments analyzed include Educational/Research, Testing Laboratories, and Pharma.

For more details about this comprehensive market research report, please click here

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site:


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website